Omega-3 fatty acids and other FFA4 agonists inhibit growth factor signaling in human prostate cancer cells.
Ze Liu, Mandi M Hopkins, Zhihong Zhang, Chrystal B Quisenberry, Louise C Fix, Brianna M Galvan, Kathryn E Meier
Index: J. Pharmacol. Exp. Ther. 352(2) , 380-94, (2015)
Full Text: HTML
Abstract
Omega-3 fatty acids (n-3 FAs) are proposed to have many beneficial effects on human health. However, the mechanisms underlying their potential cancer preventative effects are unclear. G protein-coupled receptors (GPCRs) of the free fatty acid receptor (FFAR) family, FFA1/GPR40 and FFA4/GPR120, specifically bind n-3 FAs as agonist ligands. In this study, we examined the effects of n-3 FAs in human prostate cancer cell lines. Initial studies established that the long-chain n-3 FAs, eicosapentaenoic acid (EPA) and docosahexaenoic acid, inhibit proliferation of DU145 cells in response to lysophosphatidic acid (LPA), a mitogenic lipid mediator. When added alone to serum-starved DU145 cells, EPA transiently activates signaling events, including p70S6K phosphorylation. However, when added 15 minutes prior to LPA, EPA suppresses LPA-induced activating phosphorylations of ERK, FAK, and p70S6K, and expression of the matricellular protein CCN1. The rapid onset of the inhibitory action of EPA suggested involvement of a GPCR. Further studies showed that DU145 and PC-3 cells express mRNA and protein for both FFA4 and FFA1. TUG-891 (4-[(4-fluoro-4'-methyl[1,1'-biphenyl]-2-yl)methoxy]-benzenepropanoic acid), a selective agonist for FFA4, exerts inhibitory effects on LPA- and epidermal growth factor-induced proliferation and migration, similar to EPA, in DU145 and PC-3 cells. The effects of TUG-891 and EPA are readily reversible. The FFA1/FFA4 agonist GW9508 (4-[[(3-phenoxyphenyl)methyl]amino]-benzenepropranoic acid) likewise inhibits proliferation at doses that block FFA4. Knockdown of FFA4 expression prevents EPA- and TUG-891-induced inhibition of growth and migration. Together, these results indicate that activation of FFA4 initiates signaling events that can inhibit growth factor-induced signaling, providing a novel mechanism for suppression of cancer cell proliferation. Copyright © 2015 by The American Society for Pharmacology and Experimental Therapeutics.
Related Compounds
Related Articles:
2014-10-17
[Int. J. Food Microbiol. 189 , 98-105, (2014)]
2014-01-01
[PLoS ONE 9(6) , e99421, (2014)]
2014-04-01
[Pharmacogn. Mag. 10(Suppl 2) , S383-91, (2014)]
Glucose recognition proteins for glucose sensing at physiological concentrations and temperatures.
2014-07-18
[ACS Chem. Biol. 9(7) , 1595-602, (2014)]
Reservoirs of listeria species in three environmental ecosystems.
2014-09-01
[Appl. Environ. Microbiol. 80(18) , 5583-92, (2014)]